Advertisement

Molecular Medicine

, Volume 14, Issue 11–12, pp 715–723 | Cite as

Acute, Muscle-Type Specific Insulin Resistance Following Injury

  • LaWanda H. Thompson
  • Hyeong T. Kim
  • Yuchen Ma
  • Natalia A. Kokorina
  • Joseph L. Messina
Research Article

Abstract

Acute insulin resistance can develop following critical illness and severe injury, and the mortality of critically ill patients can be reduced by intensive insulin therapy. Thus, compensating for the insulin resistance in the clinical care setting is important. However, the molecular mechanisms that lead to the development of acute injury/infection-associated insulin resistance are unknown, and the development of acute insulin resistance is much less studied than chronic disease-associated insulin resistance. An animal model of injury and blood loss was utilized to determine whether acute skeletal muscle insulin resistance develops following injury, and surgical trauma in the absence of hemorrhage had little effect on insulin-mediated signaling. However, following hemorrhage, there was an almost complete loss of insulin-induced Akt phosphorylation in triceps, and severely decreased tyrosine phosphorylation of the insulin receptor and insulin receptor substrate-1. The severity of insulin resistance was similar in triceps and extensor digitorum longus muscles, but was more modest in diaphragm, and there was little change in insulin signaling in cardiac muscle following hemorrhage. Since skeletal muscle is an important insulin target tissue and accounts for much of insulin-induced glucose disposal, it is important to determine its role in injury/infection-induced hyperglycemia. This is the first report of an acute development of skeletal muscle insulin signaling defects. The presented data indicates that the defects in insulin signaling occurred rapidly, were reversible and more severe in some skeletal muscles, and did not occur in cardiac muscle.

Notes

Acknowledgments

This work is supported by grants from the National Institutes of Health (DK62071), the Department of Defense (W81XWH-0510387), and the Veterans Administration Merit Review to JLM. A University of Alabama Comprehensive Minority Faculty and Student Development Program Fellowship provided support for LHT. We would like to acknowledge the members of the University of Alabama Center for Surgical Research for vital assistance in setting up the animal model in our lab, MM Bamman and DJ Kosek for additional technical assistance, and the Metabolism Core Laboratory of the Clinical Nutrition Research Center at University of Alabama (P30-DK56336) for the serum insulin and TNF-α measurements. We also would like to thank JL Franklin, Drs. AB Keeton, and MG Schwacha, for their helpful and insightful discussions and suggestions.

References

  1. 1.
    Avruch J. (1998) Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 182:31–48.CrossRefGoogle Scholar
  2. 2.
    White MF, Kahn CR. (1994) The insulin signaling system. J. Biol. Chem. 269: 1–4.PubMedGoogle Scholar
  3. 3.
    Zick Y. (2001) Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol. 11:437–41.CrossRefGoogle Scholar
  4. 4.
    White MF. (2002) IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283:E413–22.CrossRefGoogle Scholar
  5. 5.
    Kahn CR. (1978) Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27:1893–902.CrossRefGoogle Scholar
  6. 6.
    Ma Y, Wang P, Kuebler JF, Chaudry IH, Messina JL. (2003) Hemorrhage induces the rapid development of hepatic insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G107–15.CrossRefGoogle Scholar
  7. 7.
    Ma Y, et al. (2004) Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology 145:5168–76.CrossRefGoogle Scholar
  8. 8.
    Xu J, et al. (2008) Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor (TNF)-alpha. Endocrinology 149:2369–82.CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Carter EA. (1998) Insulin resistance in burns and trauma. Nutr. Rev. 56:S170–6.CrossRefGoogle Scholar
  10. 10.
    Allsop JR, Wolfe RR, Burke JF. (1978) Glucose kinetics and responsiveness to insulin in the rat injured by burn. Surg. Gynecol. Obstet. 147:565–73.PubMedGoogle Scholar
  11. 11.
    Turinsky J, Saba TM, Scovill WA, Chesnut T. (1977) Dynamics of insulin secretion and resistance after burns. J. Trauma 17:344–50.CrossRefGoogle Scholar
  12. 12.
    Clemens MG, Chaudry IH, Daigneau N, Baue AE. (1984) Insulin resistance and depressed gluconeogenic capability during early hyperglycemic sepsis. J. Trauma-Injury Infect. Crit. Care 24:701–8.CrossRefGoogle Scholar
  13. 13.
    Lang CH, Dobrescu C. (1989) In vivo insulin resistance during nonlethal hypermetabolic sepsis. Circulatory Shock 28:165–78.PubMedGoogle Scholar
  14. 14.
    Chaudry IH, Sayeed MM, Baue AE. (1974) Insulin resistance in experimental shock. Arch. Surg. 109:412–5.CrossRefGoogle Scholar
  15. 15.
    Strommer L, et al. (2001) Effect of carbohydrate feeding on insulin action in skeletal muscle after surgical trauma in the rat. Nutrition 17:332–6.CrossRefGoogle Scholar
  16. 16.
    Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. (2000) Insulin resistance and substrate utilization in human endotoxemia. J. Clin. Endocrinol. Metab. 85:3770–8.CrossRefGoogle Scholar
  17. 17.
    Van den Berghe G, et al. (2001) Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345:1359–67.CrossRefGoogle Scholar
  18. 18.
    Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J. Clin. En- docrinol. Metab. 88:1082–8.CrossRefGoogle Scholar
  19. 19.
    DeFronzo RA, et al. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000–7.CrossRefGoogle Scholar
  20. 20.
    Bamman MM, et al. (2004) Myogenic protein expression before and after resistance loading in 26- and 64-yr-old men and women. J. Appl. Phys- iol. 97:1329–37.CrossRefGoogle Scholar
  21. 21.
    Keeton AB, et al. (2003) Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology 144:5402–10.CrossRefGoogle Scholar
  22. 22.
    Keeton AB, Amsler MO, Venable DY, Messina JL. (2002) Insulin Signal Transduction Pathways and Insulin-induced Gene Expression. J. Biol. Chem. 277:48565–73.CrossRefGoogle Scholar
  23. 23.
    Hill MM, Feng J, Hemmings BA. (2002) Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr. Biol. 12:1251–5.CrossRefGoogle Scholar
  24. 24.
    Cline GW, et al. (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes [see comments]. N. Engl. J. Med. 341:240–6.CrossRefGoogle Scholar
  25. 25.
    Lang CH, Dobrescu C, Meszaros K. (1990) Insulinmediated glucose uptake by individual tissues during sepsis. Metabolism 39:1096–107.CrossRefGoogle Scholar
  26. 26.
    Sugita H, et al. (2005) Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288:E585–91.CrossRefGoogle Scholar
  27. 27.
    Wilmore DW, Mason AD Jr, Pruitt BA Jr. (1976) Insulin response to glucose in hypermetabolic burn patients. Ann. Surg. 183:314–20.CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Carey LC, Lowery BD, Cloutier CT. (1970) Blood sugar and insulin response of humans in shock. Ann. Surg. 172:342–50.CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Krook A. (1998) Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47:1281–6.CrossRefGoogle Scholar
  30. 30.
    Nunes AL, Carvalheira JB, Carvalho CR, Brenelli SL, Saad MJ. (2001) Tissue-specific regulation of early steps in insulin action in septic rats. Life Sci. 69:2103–12.CrossRefGoogle Scholar
  31. 31.
    Gore DC, et al. (2002) Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit. Care Med. 30:2438–42.CrossRefGoogle Scholar
  32. 32.
    Ikezu T, Okamoto T, Yonezawa K, Tompkins RG, Martyn JA. (1997) Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J. Biol. Chem. 272:25289–95.CrossRefGoogle Scholar
  33. 33.
    Vivanco I, Sawyers CL. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489–501.CrossRefGoogle Scholar
  34. 34.
    James DE, Jenkins AB, Kraegen EW. (1985) Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am. J. Physiol. 248:E567–74.PubMedGoogle Scholar
  35. 35.
    Krook A, et al. (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49:284–92.CrossRefGoogle Scholar
  36. 36.
    Klein HH, Vestergaard H, Kotzke G, Pedersen O. (1995) Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Diabetes 44:1310–7.CrossRefGoogle Scholar
  37. 37.
    Meyer MM, Levin K, Grimmsmann T, BeckNielsen H, Klein HH. (2002) Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Diabetologia 45:813–22.CrossRefGoogle Scholar
  38. 38.
    Caro JF, et al. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J. Clin. Invest. 79:1330–7.CrossRefPubMedCentralGoogle Scholar
  39. 39.
    Kim YB, Kotani K, Ciaraldi TP, Henry RR, Kahn BB. (2003) Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes 52:1935–42.CrossRefGoogle Scholar
  40. 40.
    Arner P, Pollare T, Lithell H, Livingston JN. (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:437–40.CrossRefGoogle Scholar
  41. 41.
    Maegawa H, Shigeta Y, Egawa K, Kobayashi M. (1991) Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40:815–9.CrossRefGoogle Scholar
  42. 42.
    Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky, JM. (1994) Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J. Clin. Endocrinol. Metab. 78:471–7.PubMedGoogle Scholar
  43. 43.
    Bjornholm M, Kawano Y, Lehtihet M, Zierath JR. (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46:524–7.CrossRefGoogle Scholar
  44. 44.
    Cusi K, et al. (2000) Insulin resistance differentially affects the PI 3-kinase- and MAP kinasemediated signaling in human muscle. J. Clin. Invest. 105:311–20.CrossRefPubMedCentralGoogle Scholar
  45. 45.
    Esposito DL, Li Y, Cama A, Quon MJ. (2001) Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 142:2833–40.CrossRefGoogle Scholar
  46. 46.
    Ferrando AA, et al. (1999) Asubmaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann. Surg. 229:11–8.CrossRefPubMedCentralGoogle Scholar
  47. 47.
    Mesotten D, Van den Berghe G. (2003) Clinical potential of insulin therapy in critically ill patients. Drugs 63:625–36.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2008

Authors and Affiliations

  • LaWanda H. Thompson
    • 1
  • Hyeong T. Kim
    • 2
  • Yuchen Ma
    • 1
  • Natalia A. Kokorina
    • 1
  • Joseph L. Messina
    • 1
    • 3
  1. 1.Department of Pathology, Division of Molecular and Cellular PathologyThe University of Alabama at Birmingham, Volker HallBirminghamUSA
  2. 2.Department of Internal Medicine, College of MedicinePochon CHA UniversitySeoulSouth Korea
  3. 3.Veterans Affairs Medical CenterBirminghamUSA

Personalised recommendations